medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2021, Number 3

<< Back Next >>

Rev Mex Patol Clin Med Lab 2021; 68 (3)

Metabolic differences between adolescents with adequate body mass index and those with overweight/obesity

Rivera-Cisneros AE, Sánchez-González JM, Murguía CG, Vargas SG, Noriega MI, Lara MY, Fritzler W, Portillo GJH, Franco SR

Language: Spanish
References: 21
Page: 113-117
PDF size: 199.83 Kb.


ABSTRACT

Introduction: The practice of physical activity in its sports modality is desirable among the child and youth population. The objective of this study was to identify the differences in blood metabolic levels between men with adequate body mass and overweight. Material and methods: Participants were 74 male adolescents with normal weight and 72 with overweight according to their body mass index (BMI). The participants were assigned to two groups: group I (GI) with participants with a BMI = 20 to 25 (kg/m2) and group II (GII) with BMI > 25 (kg/m2). In all cases, body dimension was measured, and analyzed the biomarkers: glucose (Gluc), total cholesterol (TC), triglycerides (TG) and high (HDL-C), low (LDL-C) and very low density (VLDL-C) lipoproteins. Results: The body weight (GI = 58.93 ± 7.82 vs GII = 75.7 ± 14.10 kg), the body mass index (GI = 21.80 ± 1.81 vs GII = 29.08 ± 4.07), Gluc levels (mmol/L) (GI = 4.70 ± 0.28 vs GII = 4.97 ± 0.41), TG (mmol/L) (GI = 1.09 ± 0.39 vs GII = 1.24 ± 0.38) and VLDL-C (mmol/L) (GI = 0.46 ± 0.10 vs GII = 0.52 ± 0.2), were higher in the overweight/obese group (p < 0.05). A one-way analysis of variance was performed to assess the difference between groups, with alpha at 95%. Conclusion: It is considered necessary to include studies that assess the metabolic status of participants in sports activities, particularly in adolescents with high weight (BMI > 25 kg/m2).


REFERENCES

  1. World Health Organization (WHO). Noncommunicable diseases: Childhood overweight and obesity. Geneva: WHO; 2020. Available in: http://www.who.int/dietphysicalactivity/childhood/en/

  2. Rivera-Dommarco J, Colchero A, Fuentes M, Aguilar-Salinas C, Hernández-Licona G, Barquera S et al La obesidad en México. Estado de la política pública y recomendaciones para su prevención y control. Cuernavaca: Instituto Nacional de Salud Pública; 2018. Disponible en: https://www.slaninternacional.org/publicaciones/docs/LaObesidadenMexico.pdf

  3. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011; 121 (6): 2111-2117.

  4. Christensen DL, Espino D, Infante-Ramírez R, Cervantes-Borunda MS, Hernández-Torres RP, Rivera-Cisneros AE et al. Transient cardiac dysfunction but elevated cardiac and kidney biomarkers 24 h following an ultra-distance running event in Mexican Tarahumara. Extrem Physiol Med. 2017; 6: 3. doi: 10.1186/s13728-017-0057-5.

  5. Sebeková K, Somoza V, Jarcusková M, Heidland A, Podracká L. Plasma advanced glycation end products are decreased in obese children compared with lean controls. Int J Pediatr Obes. 2009; 4 (2): 112-118.

  6. Accacha S, Rosenfeld W, Jacobson A, Michel L, Schnurr FJ, Shelov S et al. Plasma advanced glycation end products (AGEs), receptors for AGEs and their correlation with inflammatory markers in middle school-age children. Horm Res Paediatr. 2013; 80 (5): 318-327.

  7. Rowisha M, El-Batch M, El Shikh T, El Melegy S, Aly H. Soluble receptor and gene polymorphism for AGE: relationship with obesity and cardiovascular risks. Pediatr Res. 2016; 80 (1): 67-71.

  8. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, Franco A, Cuevas-Nasu L et al. Encuesta nacional de salud y nutrición 2012. Resultados nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública (MX); 2012.

  9. Instituto Nacional de Estadística y Geografía. Prevalencia de obesidad, hipertensión y diabetes para los municipios de México 2018. Estimación para áreas pequeñas. 2020. Disponible en: https://www.inegi.org.mx/contenidos/investigacion/pohd/2018/doc/a_peq_2018_nota_met.pdf

  10. INEGI. Módulo de Práctica Deportiva y Ejercicio Físico (MOPRADEF) 2019 y 2020. Disponible en: https://www.inegi.org.mx/

  11. Rivera-Cisneros AE, Sánchez-González JM, Reinoso Vázquez V, Fritzler W, Martínez-Vega KR, Vargas-Sánchez G. Niveles plasmáticos de creatinfosfoquinasa y deshidrogenasa láctica en jugadores profesionales de fútbol. Rev Mex Patol Clin Med Lab. 2021; 68 (1): 4-10.

  12. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000; 320 (7244): 1240-1243.

  13. Tanner JM. Growth at adolescence. 2nd ed. Springfield: Thomas, Springfield, Illinois; 1962.

  14. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993; 269 (23): 3015-3023.

  15. Accacha S, Rosenfeld W, Jacobson A, Michel L, Schnurr FJ, Shelov S et al. Plasma advanced glycation end products (AGEs), receptors for AGEs and their correlation with inflammatory markers in middle school-age children. Horm Res Paediatr. 2013; 80 (5): 318-327.

  16. Mastroeni SS, Mastroeni MF, Goncalves Mde C, Debortoli G, da Silva NN, Bernal RT et al. Cardiometabolic risk markers of normal weight and excess body weight in Brazilian adolescents. Appl Physiol Nutr Metab. 2016; 41 (6): 659-665.

  17. Escobedo-de la Peña J, De Jesús-Pérez R, Schargrodsky H, Champagne B. Prevalencia de dislipidemias en la ciudad de México y su asociación con otros factores de riesgo cardiovascular. Resultados del estudio CARMELA. Gac Med Mex. 2014; 150 (2): 128-136.

  18. Ramírez GMM, Núñez PAB, Velázquez MH, Tejeda KOA, Cortés BB, Parra IA et al. Alteraciones cardiovasculares en una población infantil y su relación con trastornos metabólicos y antropométricos. Rev Esp Med Quir. 2011; 16 (4): 199-207.

  19. Vázquez CC, Salinas OS, Gómez DRA, Rosso JMM, Jiménez VM, Argüero SR. What is the insulin level in a Mexican people with normal body mass index? Rev Endocrinol Nutr. 2003; 11 (1): 22-27.

  20. Salinas-Martínez AM, Hernández-Herrera RJ, Mathiew-Quirós A, González-Guajardo EE. Obesidad central única y combinada con sobrepeso/obesidad en preescolares mexicanos. ALAN. 2012; 62 (4): 331-338.

  21. Hidalgo y Teran Elizondo R, Martín Bermudo FM, Peñaloza Mendez R, Berná Amorós G, Lara Padilla E, Berral de la Rosa FJ. Nutritional intake and nutritional status in elite Mexican teenagers soccer players of different ages. Nutr Hosp. 2015; 32 (4): 1735-1743. doi: 10.3305/nh.2015.32.4.8788.




2020     |     www.medigraphic.com